ABX NYSE Week ended 31 Jul 2026

Weekly Investor Report

Abacus Global Management, Inc. · Financial Services · Insurance - Life

Open interactive chart View report data
Latest close 10.31 USD
-0.7% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 12.3% above the Trend Line and sits at 71.9% of its 52-week range. The latest completed week returned -0.7%, after a -13.1% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 36/100 conviction, while the latest news-sentiment score is 56/100. Near-term considerations: volume confirmation is below normal; earnings are due in 4d.

Setup score 58 out of 100
Latest Close 10.31 USD 31 Jul 2026
1W Return -0.7% latest completed week
4W Return -13.1% short-term follow-through
12W Return 13.5% quarterly tape
Trend Breadth 65.4% 34 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • The trend backdrop is active with a 34-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.7% Latest completed week; four-week move -13.1%. Indicator stack 81/74 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Mixed 36/100 conviction; expected move 13.6%. News sentiment 56/100 31 relevant articles in the latest sentiment read. Event risk 4d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 12.3% above the Trend Line and sits at 71.9% of its 52-week range. The latest completed week returned -0.7%, after a -13.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8312-week average 0.74

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.83Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -13.1% over four weeks, 13.5% over 12 weeks, and 101.0% over one year. The current trend has remained active for 34 consecutive weeks.

Performance by holding period

1W-0.7%
4W-13.1%
12W13.5%
26W38.4%
52W101.0%
Active trend streak34 weeks
Active weeks in one year34
Trend breadth65.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.88Latest activity-pressure read.
Pressure change107.2%Four-week change in activity pressure.
Leadership18.85Latest relative-leadership reading.
RS change-56.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength95/100Blend of value, momentum, and quality. Underlying universe rank 6; rank 1 is best.
Value73/100Relative valuation strength. Underlying universe rank 28; rank 1 is best.
Quality91/100Profitability and accounting quality. Underlying universe rank 10; rank 1 is best.
Momentum94/100Medium-term price momentum. Underlying universe rank 7; rank 1 is best.
Growth98/100Revenue and earnings growth. Underlying universe rank 3; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
25.4x
Price divided by trailing earnings.
Price / sales
4.0x
Market value relative to trailing revenue.
EV / EBITDA
11.5x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
9.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
70.8%
Gross profit retained from each unit of revenue.
Operating margin
38.2%
Operating profit retained from revenue.
Free-cash-flow margin
51.6%
Free cash flow generated from revenue.
Return on invested capital
9.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
86.1%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.9%
Cash dividends relative to market value.
Buyback yield
5.8%
Net share repurchases relative to market value.
Shareholder yield
7.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

ABX shows mixed options pressure with a 36/100 conviction score, put-call volume ratio of 1.00, expected move of 13.6%, and Sharemaestro trend signal active.

Conviction36/100
Expected move13.6%
Put/call volume1.00
Pressure7
Speculation0
Volatility90
Trend agreement92
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment56/100

Weighted news tone is neutral across 31 relevant articles.

11 positive · 20 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move13.6%Nearest-chain priced movement where available.
52-week drawdown-17.1%Distance below the 52-week high.
13-week volatility7.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+19.7%Week of 3 Jul.
Worst week-8.4%Week of 20 Mar.
Latest week-0.7%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains5
Flat weeks0
Modest losses10
Sharp losses4
Recent vol7.0%13-week weekly-return volatility.
Base vol8.4%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew8.3% / -4.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape64/100

Trend, activity pressure, participation, and risk combine to a 64/100 tape read.

 Indicator analysis72/100

Latest 12-week confirmation: trend 12/12, activity pressure 5/12, relative leadership 12/12.

Activity pressure 0.83; 2 reversal markers Factors88/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 10; Small Cap Core rank 39 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options58/100

ABX shows mixed options pressure with a 36/100 conviction score, put-call volume ratio of 1.00, expected move of 13.6%, and Sharemaestro trend signal active.

Mixed · Options-market disagreement · Expected move 13.6% Sentiment56/100

Weighted news tone is neutral across 31 relevant articles.

Is Abacus Global Management (ABX) A Bargain As Its New Longevity Fund Draws Interest? Insiders50/100

No recent insider transaction evidence is stored.

 Earnings4d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202610.31 USD-0.7%9.18 USD8.33 USD0.8818.852.1MOn
24 Jul 202610.38 USD0.2%9.10 USD8.30 USD1.2922.072.8MOn
17 Jul 202610.36 USD-6.8%9.04 USD8.30 USD1.3822.343.9MOn
10 Jul 202611.11 USD-6.3%8.97 USD8.30 USD0.9730.503.9MOn
3 Jul 202611.86 USD19.7%8.88 USD8.29 USD0.4342.913.4MOn
26 Jun 20269.91 USD7.1%8.71 USD8.28 USD-0.2223.604.1MOn
19 Jun 20269.25 USD-3.5%8.60 USD8.28 USD-0.6113.862.5MOn
12 Jun 20269.59 USD9.5%8.48 USD8.29 USD-0.5819.841.9MOn
5 Jun 20268.76 USD-2.4%8.37 USD8.29 USD-0.4910.682.6MOn
29 May 20268.98 USD-0.7%8.29 USD8.30 USD-0.2511.012.0MOn
22 May 20269.04 USD-0.6%8.15 USD8.30 USD-0.0813.182.5MOn
15 May 20269.09 USD0.1%8.04 USD8.31 USD-0.0314.452.8MOn
8 May 20269.08 USD-3.8%7.91 USD8.32 USD-0.0414.073.3MOn
1 May 20269.44 USD2.5%7.79 USD8.32 USD-0.1520.732.4MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.